THGPSAnnex 1 Questionnaire expert surveyWord下载.docx

THGPSAnnex 1 Questionnaire expert surveyWord下载.docx

《THGPSAnnex 1 Questionnaire expert surveyWord下载.docx》由会员分享，可在线阅读，更多相关《THGPSAnnex 1 Questionnaire expert surveyWord下载.docx（40页珍藏版）》请在冰豆网上搜索。

ThisprojectiscommissionedbytheBelgianSciencePolicyandsupportedbytheEuropeanMonitoringCentreforDrugsandDrugAddiction

Introduction

AlthoughBelgiumputsinagreatefforttogaininsightintotheepidemiologicsituationconcerningdruguse（e.g.amongtheschool-goingyouth）,Belgiumhasnoextendedresearchtraditioninrelationtotheprevalenceofdruguse.Sofar,theprevalenceofdrugusewithinthegeneralBelgianpopulationhasneverbeenstudied.Theaimofthisresearchisafeasibilitystudyofarepetitivesurveyamongthegeneralpopulation.ThefeasibilitystudyiscommissionedbytheBelgianSciencePolicy 

（）andcarriedoutbytheInstituteforSocialDrugResearch（Prof.DrTomDecorte,UniversityofGhent）andtheResearchCentreforLongitudinalandLifeCourseStudies（Prof.DrDimitriMortelmans,UniversityofAntwerp）.

MostEuropeancountrieshavealreadyconductedoneormoregeneralpopulationsurveys,butthereareimportantintrinsicandmethodological-technicaldifferences.OurresearchcoversadetailedcomparisonofprevalencestudiesinotherEuropeancountries,andincludesalimitedcognitivetestoftheincludeditemswithaviewtotheimplementationofsuchstudyinBelgium.Thefeasibilitystudyiscomposedoffivefoci:

intrinsicfocus（whichconcepts,prevalenceindicators,characteristicsofdruguse,socio-demographiccharacteristics,lifestyleindicatorsandattitudesaretobeincludedintheinstrument）,methodologicalfocus（datacollectionmethod,samplesize（sampleframe,overrepresentations,weighting,size）,frequencyofthesurvey,etc.）,comparativefocus（comparabilitywithnationalandinternationalsurveys）,financialfocus（generalcostsinrelationtothechoicesofdatacollectionandlengthofthequestionnaire）andvalorisationfocus（feasibilityanddesirabilityofthedistributionmodeofthefindings）.

Inthefirstphaseofthisstudywestudiedtheinternationalrecommendationsregardingmeasurementofdruguseinthegeneralpopulation（EMCDDA,WHO,etc.）Furthermore,ameta-analysisofallexistingprevalencestudiesinEuropeismade.Themeta-analysisofgeneralpopulationsurveyscoversadetailedcomparisonofitemsandquestionmodules,methodsanddesigns,usedinprevalencestudiesinotherEuropeancountries,andtheevaluationofstrengths,restrictions,preconditionsandcostsofthesestudies.Afirstdraftofthismeta-analysisisincludedintheappendix.

AllexpertsresponsiblefornationalpopulationsurveysintheEuropeanUnionareinvitedtocompletethisquestionnaire.Wewouldliketoaskyousomequestionsaboutseveralaspectsofthedesignandtheorganisationofgeneralpopulationsurveysondrugsinyourcountry.Thequestionnaire,developedinclosecooperationwiththeEMCDDA,givesspecialattentiontothelegitimationsforchoicesthatweremadeandto（reasonsfor）deviationsfromEuropeanguidelines,andalsototheimpactofgeneralsocial,culturalandpoliticalpracticesinacountryonthedesignofthestudyandspecificimplicationsandlimitationsofthenationalcontext.Thequestionnairealsofocusesonthecomparabilityandvalorizationofthedata.Nexttogaininginsightintheexperiencesandknow-howofthenationalexperts,youranswersmayhelpustocompleteandup-datetheoverviewofgeneralpopulationssurveyspreviouslymadebytheEMCDDA 

（）.

Asaresult,aproposalofa‘bestfit’designforaBelgianpopulationsurveyondrugusewillbedevelopedandtested.ThismustenableBelgianpolicymakerstodecidewhetherornotandhowtoimplementanationalprevalencestudy.

ThefinalreportwillbeavailableinDutchandEnglishattheendof2008.

Howtofillinthequestionnaire?

Thequestionsarerelatedtothe‘RelazioneAnnualealParlamentosulloStatodelleTossicodipendenzeinItalia’administeredintheyears2001,2003and2005.

Thequestionnairecontainsfourparts.First,somegeneralquestionsareasked,followedbydetailedquestionsaboutintrinsic（A.）andmethodologicalaspects（B.）inordertocompletetheEMCDDAoverview（2001）.Thequestionnaireendswithsomequestionsaboutfinancial（C.）andvalorisationaspects（D.）.Ittakesabout40minutestocompletethisquestionnaire.

Thequestionnairecanbecompletedintheelectronicversion（recommended）oronaprintedversion.Wekindlyaskyoutoreturnthequestionnairebye-mail,postalserviceorfaxatthelatestbefore19May2008.Thecontactinformationcanbefoundattheendofthisquestionnaire.

Open-endedquestionsmaybeansweredbytyping/writingtheanswerintheprovidedspace.Inaddition,thereareseveralmultiplechoicequestions.Thesequestionscanbeansweredbyclicking/tickingonthebox（）besidesthecorrectanswer.

Giventheimportanceofandusefulnessofthismeta-analysisofgeneralpopulationsurveysondrugsformanyexpertsaroundEurope,wehopeforyourparticipationandexpressourgratitudeinadvance.

Yourstruly,

A.Generalquestions

Thefollowingquestionsareonlyrelatedto‘RelazioneAnnualealParlamentosulloStatodelleTossicodipendenzeinItalia’administeredintheyear2005.

1.Thesurveyhasbeencarriedoutat:

Nationallevelonly

Other,pleasespecify

2.Whatwasthetypeofsurvey:

Single:

surveydealtwithdrugs（and/oralcohol,tobaccoandpharmaceuticals）only

Pleasespecifywhyitwasdecidedtodevelopa‘single’survey（andwhy,forexample,thesurveywasnotsetupby‘piggybacking’iftherewasanopportunity）.

Multi:

questionsaboutdrugusewerepartofasurveywithawiderscope（piggybacking）

Pleasespecifythetypeofsurvey:

Healthsurvey

Crimesurvey

Whatwas/werethereason（s）forpiggybacking?

Lowercost

Obtaininginformationaboutrelateditems（e.g.health,crime）

Didyourresearchteamevaluatetheimpactofthecontext（e.g.health,crime）onprevalencerates?

Ifyes,couldyouelaborateonthereflectionsmade?

3.Describethemainobjectivesandresearchquestionsthesurveywantedtoanswer:

（a）

（b）

（c）

（d）

4.Whowasthecommissionerofthesurvey（theauthorityorinstitutethatinitiatedandcommissionedthesurvey?

）

Thegovernment（e.g.MinistryofHealth）

Pleasespecifywhichministryordepartment

Anacademicinstitution（e.g.university）

Pleasespecifywhichfacultyorresearchcentre

Aprivate/commercialcompany（e.g.researchagency）

Pleasespecifywhich

5.Whowastheresponsibleagentofthesurvey（theinstituteororganisationthatwasinchargefortheorganisationandanalysisofthesurvey）?

6.Frequencyofthesurvey:

Eachyear（annually）

Everyyears（example:

every2years,3years,4years,etc.）

Everytoyears（example:

every3to4years）

7.Canyouspecifythereason（s）whytheresearchteamchosetoconductthesurveyasfrequentlyasindicatedinthepreviousquestion?

8.Year（s）inwhichasimilarsurveywascarriedoutinyourcountryinthepast:

9.Year（s）inwhichasimilarsurveywillbecarriedoutinthefuture:

10.Whatwasthedatacollectionmethod?

Mail

Telephone

Computer-assistedtelephoneinterviewing（CATI）

Notcomputerassisted

Face-to-face

Computer-assistedpersonalinterviewing（CAPI）

Computer-assistedselfinterviewing（CASI）

Penandpaper

Web-basedsurvey

Otherpleasespecify

11.Howdoyoumotivatethechoiceforthismodeofinterviewing?

12.IsthequestionnairecompatiblewiththerecommendationsoftheEuropeanMonitoringCentreforDrugsandDrugAddiction（EMCDDA）?

No

Yes

HowdoyouassessthecomparabilityofyourquestionnairetotheEuropeanModelQuestionnaire（EMQ）?

FullycomparabletotheEMQ

HighlycomparabletotheEMQ

ModeratelycomparabletotheEMQ

LittlecomparabletotheEMQ

NotcomparabletotheEMQ

PleasespecifytowhatextentthequestionnairedeviatesfromtheEMCDDArecommendations

Concerningtheintrinsicaspects（timeframes:

LTP,LYP,TMP;

frequencyandageoffirstuse;

numberofillicitdrugs;

inclusionofnewproducts;

inclusion/exclusionofadummydrug…）

Pleasespecifyhow:

Pleasespecifywhy:

Concerningthemethodologicalaspects

（TheEMCDDAisnotveryprescriptiveonthispoint.However,thefollowingaspectsarerecommended:

probabilisticsample,regularsurveys,maintainmethodologyandsample,abigenoughsampleandresultsshouldbereproducible…）

13.IsthequestionnairecompatiblewiththerecommendationsoftheWorldHealthOrganization（WHO）?

Pleasespecifytowhatextentthequestionnairedeviatesfromtherecommendations

Concerningtheintrinsicaspects（numberofillicitdrugs,inclusionofnewproducts,inclusion/exclusionofadummydrug…）

Concerningthemethodologicalaspects（samplesize,samplingframe,datacollectionmethod…）

14.HaveyoualsocheckedtheEuropeanSchoolS